Fig. 2From: Liver stiffness, hepatorenal index, and microRNA-130b as predictors for chronic kidney disease in patients with non-alcoholic fatty liver diseaseDiagnostic performance and ROC analysis of microRNA-130b in discrimination of different study groups. a All patients vs. healthy control. b Nonalcoholic fatty liver disease associated with chronic kidney disease vs. nonalcoholic fatty liver disease but without chronic kidney disease. c Nonalcoholic fatty liver disease without chronic kidney disease vs. healthy controlBack to article page